Figure 4
Figure 4. The redox state of Prx2 in 5 μM H2O2-treated erythrocytes over time. (A) A representative immunoblot of the redox transitions of Prx2 following a bolus treatment with 5 μM H2O2. (B) Extracellular H2O2 levels over time after a bolus treatment of 5 μM H2O2. Data are the means ± SD from 3 experiments. (C) Jurkat cells were pretreated with 30 μM DNCB for 10 minutes prior to the indicated concentrations of H2O2, then immunoblotted (30 μg protein per lane). (D) The inhibition of erythrocyte Prx2 regeneration by treatment with 30 μM DNCB prior to 5 μM H2O2. D indicates dimeric Prx2; M, monomeric Prx2.

The redox state of Prx2 in 5 μM H2O2-treated erythrocytes over time. (A) A representative immunoblot of the redox transitions of Prx2 following a bolus treatment with 5 μM H2O2. (B) Extracellular H2O2 levels over time after a bolus treatment of 5 μM H2O2. Data are the means ± SD from 3 experiments. (C) Jurkat cells were pretreated with 30 μM DNCB for 10 minutes prior to the indicated concentrations of H2O2, then immunoblotted (30 μg protein per lane). (D) The inhibition of erythrocyte Prx2 regeneration by treatment with 30 μM DNCB prior to 5 μM H2O2. D indicates dimeric Prx2; M, monomeric Prx2.

Close Modal

or Create an Account

Close Modal
Close Modal